Movement Disorders (revue) - Checkpoint (PascalFrancis)

Index « FC03.fr.i » - entrée « Association médicamenteuse »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Association morbide < Association médicamenteuse < Association professionnelle  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 21.
[0-20] [0 - 20][0 - 21][20-20][20-40]
Ident.Authors (with country if any)Title
001110 (2008) Birgit Meiler [Allemagne] ; Jürgen Andrich [Allemagne] ; Thomas Müller [Allemagne]Rapid Switch from Oral Antiparkinsonian Combination Drug Therapy to Duodenal Levodopa Infusion
002387 (2003) Claudia Trenkwalder [Allemagne] ; Victor Collado Seidel [Allemagne] ; Jörg Kazenwadel [Suisse] ; Thomas C. Wetter [Allemagne] ; Wolfgang Oertel [Allemagne] ; Roland Selzer [Allemagne] ; Ralf Kohnen [Allemagne]One-year treatment with standard and sustained-release levodopa: Appropriate long-term treatment of restless legs syndrome?
002419 (2003) Jau-Shin Lou [États-Unis] ; Greg Kearns [États-Unis] ; Theodore Benice [États-Unis] ; Barry Oken [États-Unis] ; Gary Sexton [États-Unis] ; John Nutt [États-Unis]Levodopa improves physical fatigue in Parkinson's disease: A double-blind, placebo-controlled, crossover study
002467 (2003) Marc Ziegler [France] ; Alexandre Castro-Caldas [Portugal] ; Susanna Del Signore [France] ; Olivier Rascol [France]Efficacy of Piribedil as early combination to levodopa in patients with stable Parkinson's disease: A 6-month, randomized, placebo-controlled study
002838 (2002) Jakob Christensen [Danemark] ; Erik Dupont [Danemark] ; Karen Stergaard [Danemark]Cabergoline plasma concentration is increased during concomitant treatment with itraconazole
002919 (2001) William Koller [États-Unis] ; Andrew Lees (neurologue) [Royaume-Uni] ; Miroslava Doder [Royaume-Uni] ; Mariese Hely [Australie]Randomized trial of tolcapone versus pergolide as add-on to levodopa therapy in Parkinson's disease patients with motor fluctuations
002A60 (2001) Eleni C. Maratos [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Ronald K. B. Pearce [Royaume-Uni] ; Peter Jenner [Royaume-Uni]Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naïve MPTP-lesioned common marmosets (Callithrix jacchus)
002B03 (2000) C. Ramaker [Pays-Bas] ; W. J. T. Van De Beek [Pays-Bas] ; M. J. J. Finken [Pays-Bas] ; B. J. J. Van Hilten [Pays-Bas]The efficacy and safety of adjunct bromocriptine therapy for levodopa-induced motor complications : A systematic review
002E24 (1999) Efficacy and tolerability of tolcapone compared with bromocriptine in levodopa-treated Parkinsonian patients
002E25 (1999) R. B. Innis [États-Unis] ; K. L. Marek [États-Unis] ; K. Sheff [États-Unis] ; S. Zoghbi [États-Unis] ; J. Castronuovo [États-Unis] ; A. Feigin [États-Unis] ; J. P. Seibyl [États-Unis]Effect of treatment with L-dopa/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [123I]β-CIT
003027 (1998) J. S. Schneider [États-Unis] ; A. Pope-Coleman [États-Unis] ; M. Van Velson [États-Unis] ; F. Menzaghi [États-Unis] ; G. K. Lloyd [États-Unis]Effects of SIB-1508Y, a novel neuronal nicotinic acetylcholine receptor agonist, on motor behavior in parkinsonian monkeys
003096 (1998) R. A. Hauser [États-Unis] ; E. Molho [États-Unis] ; H. Shale [États-Unis] ; S. Pedder [États-Unis] ; E. E. Dorflinger [États-Unis]A pilot evaluation of the tolerability, safety, and efficacy of tolcapone alone and in combination with oral selegiline in untreated Parkinson's disease patients
003127 (1997) J. P. Larsen [Norvège] ; J. Boas [Danemark]The effects of early selegiline therapy on long-term levodopa treatment and parkinsonian disability : An interim analysis of a Norwegian-Danish 5-year study
003449 (1995) J. C. Garcia-Monco [Espagne] ; A. Padierna ; M. G. BeldarrainSelegiline, fluoxetine, and depression in Parkinson's disease
003455 (1995) M. Di Capua [Italie] ; E. BertiniRemission in dihydroxyphenylalanine-responsive dystonia
003648 (1994) C. W. Olanow [États-Unis] ; S. Fahn ; M. Muenter ; H. Klawans ; H. Hurtig ; M. Stern ; I. Shoulson ; R. Kurlan ; J. D. Grimes ; Joseph Jankovic [États-Unis] ; M. Hoehn ; C. H. Markham ; R. Duvoisin ; O. Reinmuth ; H. A. Leonard ; E. Ahlskog ; R. Feldman ; L. Hershey ; M. D. YahrA multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet® in Parkinson's disease
003735 (1993) S. A. Factor [États-Unis] ; W. J. WeinerEarly combination therapy with bromocriptine and levodopa in Parkinson's disease
003759 (1993) M. Guttman [Canada] ; G. Leger ; A. Reches ; A. Evans ; H. Kuwabara ; J. M. Cedarbaum ; A. GjeddeAdministration of the new COMT inhibitor OR-611 increases striatal uptake of fluorodopa
003821 (1992) B. Gomez-Mancilla [Canada] ; R. Boucher ; P. J. BedardEffect of LY 171555 and CY 208-243 on tremor suppression in the MPTP monkey model of Parkinsonism
003955 (1990) J. Vaamonde ; M. R. Luquin ; J. A. ObesoDopaminergic responsiveness to apomorphine after chronic treatment with subcutaneous lisuride infusion in Parkinson's disease
003A09 (1989) Joseph Jankovic [États-Unis] ; K. Schwartz ; C. Vander LindenComparison of Sinemet CR4 and standars Sinemet: double blind and long-term open trial in Parkinsonian patients with fluctuations

List of associated Author.i

Nombre de
documents
Descripteur
2Joseph Jankovic
1A. Evans
1A. Feigin
1A. Gjedde
1A. Padierna
1A. Pope-Coleman
1A. Reches
1Alexandre Castro-Caldas
1Andrew Lees (neurologue)
1B. Gomez-Mancilla
1B. J. J. Van Hilten
1Barry Oken
1Birgit Meiler
1C. H. Markham
1C. Ramaker
1C. Vander Linden
1C. W. Olanow
1Claudia Trenkwalder
1E. Ahlskog
1E. Bertini
1E. E. Dorflinger
1E. Molho
1Eleni C. Maratos
1Erik Dupont
1F. Menzaghi
1G. K. Lloyd
1G. Leger
1Gary Sexton
1Greg Kearns
1H. A. Leonard
1H. Hurtig
1H. Klawans
1H. Kuwabara
1H. Shale
1I. Shoulson
1J. A. Obeso
1J. Boas
1J. C. Garcia-Monco
1J. Castronuovo
1J. D. Grimes
1J. M. Cedarbaum
1J. P. Larsen
1J. P. Seibyl
1J. S. Schneider
1J. Vaamonde
1Jakob Christensen
1Jau-Shin Lou
1John Nutt
1Jörg Kazenwadel
1Jürgen Andrich
1K. L. Marek
1K. Schwartz
1K. Sheff
1Karen Stergaard
1L. Hershey
1M. D. Yahr
1M. Di Capua
1M. G. Beldarrain
1M. Guttman
1M. Hoehn
1M. J. J. Finken
1M. Muenter
1M. R. Luquin
1M. Stern
1M. Van Velson
1Marc Ziegler
1Mariese Hely
1Michael J. Jackson
1Miroslava Doder
1O. Reinmuth
1Olivier Rascol
1P. J. Bedard
1Peter Jenner
1R. A. Hauser
1R. B. Innis
1R. Boucher
1R. Duvoisin
1R. Feldman
1R. Kurlan
1Ralf Kohnen
1Roland Selzer
1Ronald K. B. Pearce
1S. A. Factor
1S. Fahn
1S. Pedder
1S. Zoghbi
1Susanna Del Signore
1Theodore Benice
1Thomas C. Wetter
1Thomas Müller
1Victor Collado Seidel
1W. J. T. Van De Beek
1W. J. Weiner
1William Koller
1Wolfgang Oertel

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/FC03.fr.i -k "Association médicamenteuse" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/FC03.fr.i  \
                -Sk "Association médicamenteuse" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    indexItem
   |index=    FC03.fr.i
   |clé=    Association médicamenteuse
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024